• News
  • SAN DIEGO
  • Health

Neurocrine Biosciences granted two patents

Neurocrine Biosciences Inc. (Nasdaq: NBIX) has announced that two more patents have been granted related to the company's proprietary Vesicular Monoamine Transporter 2 inhibitor.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Neurocrine Biosciences Inc.

Company Website

12790 El Camino Real
San Diego, CA 92130

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
NBIX
39.5
  -3.87  
- 8.92%
1,208,142,000
45.36
12.63

Insider Trade Data

Date Insider Shares Type Value
04/08/2015 Nevinny, Corinne Helene 15,000 Exchange $71,400
02/23/2015 Grigoriadis, Dimitri E 20,000 Sell $800,000
02/23/2015 Grigoriadis, Dimitri E 20,000 Exchange $115,200
02/23/2015 Grigoriadis, Dimitri E 20,000 Sell $800,000
02/23/2015 Grigoriadis, Dimitri E 20,000 Exchange $115,200

Neurocrine Biosciences Inc. Executive(s):

Kevin Gorman

  • Chief Executive Officer, President

Similar Companies

NAICS - 541711 - Research and Development in Biotechnology
Subscribe Today!